ES2035292T3 - Solucion acuosa catartica. - Google Patents

Solucion acuosa catartica.

Info

Publication number
ES2035292T3
ES2035292T3 ES198888305942T ES88305942T ES2035292T3 ES 2035292 T3 ES2035292 T3 ES 2035292T3 ES 198888305942 T ES198888305942 T ES 198888305942T ES 88305942 T ES88305942 T ES 88305942T ES 2035292 T3 ES2035292 T3 ES 2035292T3
Authority
ES
Spain
Prior art keywords
liter
grams
solution
aqueous solution
catartical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888305942T
Other languages
English (en)
Inventor
Herbert G. Hechter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EZ Em Inc
Original Assignee
EZ Em Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EZ Em Inc filed Critical EZ Em Inc
Application granted granted Critical
Publication of ES2035292T3 publication Critical patent/ES2035292T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

SE PROPORCIONA UNA DISOLUCION PURGANTE ACUOSA Y METODO PARA LIMPIAR EL INTESTINO. LA DISOLUCION ES ISOTONICA, TIENE UN EFECTO TAMPON MINIMO SOBRE LA SANGRE HUMANA Y ES ESENCIALMENTE INORGANICA. LA DISOLUCION ACUOSA TIENE APROXIMADAMENTE 3,5 G/L DE SULFATO SODICO, 4,82 G/L DE SULFATO MAGNESICO, 1,9 G/L DE BICARBONATO SODICO, 3,85 G/L DE CLORURO SODICO, 0,746 G/L DE CLORURO POTASICO. PARA LIMPIAR EL INTESTINO USUALMENTE SE ADMINISTRAN A UN PACIENTE ENTRE 3,0 Y 4,0 LITROS DE LA DISOLUCION.
ES198888305942T 1987-07-10 1988-06-30 Solucion acuosa catartica. Expired - Lifetime ES2035292T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7186887A 1987-07-10 1987-07-10

Publications (1)

Publication Number Publication Date
ES2035292T3 true ES2035292T3 (es) 1993-04-16

Family

ID=22104118

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888305942T Expired - Lifetime ES2035292T3 (es) 1987-07-10 1988-06-30 Solucion acuosa catartica.

Country Status (9)

Country Link
US (1) US4975286A (es)
EP (1) EP0298655B1 (es)
JP (1) JP2774106B2 (es)
AT (1) ATE75141T1 (es)
CA (1) CA1326454C (es)
DE (1) DE3870335D1 (es)
ES (1) ES2035292T3 (es)
GR (1) GR3004897T3 (es)
IL (1) IL86859A (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6447763B1 (en) * 1998-06-12 2002-09-10 Ian L. Gordon Method and system for production and collection of lavage induced stool (LIS) for chemical and biologic tests of cells
RU2178696C2 (ru) * 2000-03-22 2002-01-27 Маткевич Виктор Анатольевич Энтеральная смесь для кишечного лаважа, коррекции метаболических расстройств организма, профилактики и лечения дисбактериоза кишечника
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US6946149B2 (en) * 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
US6996500B2 (en) * 2002-10-30 2006-02-07 Hewlett-Packard Development Company, L.P. Method for communicating diagnostic data
US7049319B2 (en) * 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method
US20050100637A1 (en) 2003-11-12 2005-05-12 Robert Murray Carbohydrate and electrolyte replacement composition
WO2005061008A1 (en) * 2003-12-01 2005-07-07 The United States Of America As Represented By The Secretary Of The Navy Bowel preparation for virtual colonscopy
US8435590B2 (en) * 2008-11-24 2013-05-07 Stokely-Van Camp, Inc. Use of novel carbohydrates and carbohydrate blends to provide a sports beverage with increased absorption
PH12013500224A1 (en) 2010-08-04 2013-04-08 Borody Thomas J Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
CN103338768B (zh) 2010-12-13 2019-04-19 萨利克斯药品有限公司 胃和结肠的配制剂及其制备和使用方法
CN105963701A (zh) 2011-01-28 2016-09-28 布伦特里实验室有限公司 用于肠道清洁的方法、组合物以及包装
MX2013010343A (es) 2011-03-09 2014-04-30 Univ Minnesota Composicion y metodos para el transplante de microbiota de colon.
RU2473330C1 (ru) * 2011-12-09 2013-01-27 Александр Павлович Погромов Средство для кишечного лаважа
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
HUE043852T2 (hu) 2012-07-27 2019-09-30 Redhill Biopharma Ltd A vastagbél kiürítésére szolgáló készítmények és a készítmények elõállítási módszerei
HUE046754T2 (hu) 2013-03-15 2020-03-30 Braintree Laboratories Inc Kettõs felhasználású orális gyógyszer kompozíció tabletták szulfát sókból és eljárás ezek alkalmazására
CA2985827A1 (en) 2015-05-14 2016-11-17 Crestovo Holdings Llc Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
AU2016268158B2 (en) 2015-05-22 2022-03-17 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US11213549B2 (en) 2016-10-11 2022-01-04 Finch Therapeutics Holdings Llc Compositions and method for treating primary sclerosing cholangitis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071537A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
CN110831606A (zh) 2017-04-05 2020-02-21 克雷斯顿沃控股公司 治疗帕金森氏病(pd)和相关疾病的组合物和方法
WO2018187464A1 (en) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions and methods for treating diverticulitis and related disorders
JP2020521760A (ja) 2017-05-26 2020-07-27 クレストヴォ・ホールディングス・エルエルシー 糞便微生物ベースの治療剤を含む凍結乾燥組成物ならびにそれを製造および使用する方法
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
WO2019032573A1 (en) 2017-08-07 2019-02-14 Finch Therapeutics, Inc. COMPOSITIONS AND METHODS FOR MAINTAINING AND RESTORING A HEALTHY INTESTINAL BARRIER
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
US11911419B2 (en) 2018-09-27 2024-02-27 Finch Therapeutics Holdings Llc Compositions and methods for treating epilepsy and related disorders
US12290538B2 (en) 2019-07-19 2025-05-06 Finch Therapeutics Holdings Llc Methods and products for treatment of gastrointestinal disorders
US12239659B2 (en) 2023-06-15 2025-03-04 Braintree Laboratories, Inc. Methods of administering safe colon cleansing compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993751A (en) * 1972-11-27 1976-11-23 Cybersol, Inc. Process for stabilizing therapeutic compositions and article
GB8512345D0 (en) * 1985-05-15 1985-06-19 Scras Anti-diarrhea compositions
EP0231356A1 (en) * 1985-08-01 1987-08-12 Braintree Laboratories, Inc. Low-sodium laxative and lavage formulation

Also Published As

Publication number Publication date
CA1326454C (en) 1994-01-25
IL86859A (en) 1991-12-15
IL86859A0 (en) 1988-11-30
EP0298655B1 (en) 1992-04-22
US4975286A (en) 1990-12-04
EP0298655A3 (en) 1989-03-08
EP0298655A2 (en) 1989-01-11
ATE75141T1 (de) 1992-05-15
DE3870335D1 (de) 1992-05-27
JP2774106B2 (ja) 1998-07-09
GR3004897T3 (es) 1993-04-28
JPS6431724A (en) 1989-02-02

Similar Documents

Publication Publication Date Title
ES2035292T3 (es) Solucion acuosa catartica.
AU4722785A (en) Initiating reperfusion treatment when heart attack symptoms are present
EP0672418A3 (en) Use of an inhibitor of adenosine monophosphate deaminase to increase extracellular adenosine.
BE887373A (fr) Solution de conservation des globiles rouges contenant de l'adenine, un sucre, du chlorure de sodium et du mannitol
UY25374A1 (es) Composiciones de apomorfina útiles en el tratamiento de disfunción sexual femenina
IT1154319B (it) Analizzatore di anidride carbonica nel flusso espiratorio finale per determinare la pressione parziale dell'anidride carbonica nel sangue arterioso di un paziente
DE69432607D1 (de) Inhalierbares kontrastmittel
DK1123094T3 (da) Terapeutiske præparater (II)
ATE87819T1 (de) Wirbelduesenwanne mit selbsttaetiger systemvorspuelung.
FI103376B1 (fi) Laite potilaan sydämen tilavuusvirran parantamiseksi
DK0396165T3 (da) Farmaceutisk præparat til oral indgift til gastrointestinal udskylning eller som katarlaxativ
IT9067204A0 (it) Dispositivo per assistenza ventricolare cardiaca, particolarmente per il ricupero della funzione miocardica depressa e per il mantenimento delle funzioni vitali dell'organismo
SE8506029L (sv) Hjert-lungsystem avsett for syresettning av en patients blod
PE33396A1 (es) Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
BR9708388A (pt) Solução aquosa de hemoglobina polimerizada piridoxilada e processo de sua preparação.
EA200000686A1 (ru) Препараты левозимендана, предназначенные для введения через слизистую оболочку
FR2604900B1 (fr) Solution physiologique pour le lavage des parties du corps humain ayant ete mises en contact avec un acide fluorhydrique et concentre pour sa preparation
IT8148348A0 (it) Procedimento per l'elettrolisi di una soluzione acquosa di cloruro al calino
IT7951184A0 (it) Procedimento per l'elettrolisi di una soluzione acquosa di cloruro alcalino
GB9106278D0 (en) Method of treatment
ES2111013T3 (es) Una composicion profilactica/terapeutica que contiene ws7622a para evitar o tratar la coagulacion intravascular diseminada, la enfermedad infecciosa cronica del tracto respiratorio o la bronquitis cronica.
FR2638966B1 (fr) Douche autonome, portable, sterile, pour le lavage des parties du corps humain ou animal agressees notamment par des produits chimiques
Kok et al. Tardive dyskinesia in schizophrenic outpatients
CA2037933A1 (en) Method of Treatment with Medical Agents
Robinson A waterbirth death in Sweden

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 298655

Country of ref document: ES